Evelo Biosciences Target of Unusually Large Options Trading (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) was the target of unusually large options trading on Wednesday. Stock traders acquired 1,885 put options on the stock. This represents an increase of approximately 1,101% compared to the typical volume of 157 put options.

Evelo Biosciences Stock Performance

The company has a market cap of $2,000.00, a price-to-earnings ratio of 0.00 and a beta of 1.59. The stock has a fifty day simple moving average of $0.03 and a 200 day simple moving average of $0.04. Evelo Biosciences has a 1 year low of $0.00 and a 1 year high of $5.27.

Evelo Biosciences Company Profile

(Get Free Report)

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.

Featured Stories

• Five stocks we like better than Evelo Biosciences
• 3 Natural Gas Stocks That Offer Great Dividend Yields
• Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
• Where to Find Earnings Call Transcripts
• How the Fed’s Rate Cut Could Supercharge These 3 ETFs
• Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
• Microsoft Stock: 3 Reasons It’s Ready to Crush Q4